SPY315.24+1.46 0.47%
DIA260.08+1.04 0.40%
IXIC10,428.34+84.46 0.82%

B of A Securities Reinstates Underperform on Puma Biotechnology, Announces $9 Price Target

B of A Securities analyst Geoff Meacham reinstates Puma Biotechnology (NASDAQ:PBYI) with a Underperform and announces $9 price target.

Benzinga · -
B of A Securities analyst Geoff Meacham reinstates Puma Biotechnology (NASDAQ: PBYI) with a Underperform and announces $9 price target.